Cynosure Group’s C4 Therapeutics CCCC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
Sell
-10,007
Closed -$57K 370
2024
Q3
$57K Buy
+10,007
New +$57K 0.01% 369